Two spatially distant epitopes of human lactoferrin

Hybridoma

Volumn 15, Issue 4, 1996, Pages 263-269

  Caccavo, Domenico ^a   Afeltra, Antonella ^a   Guido, Francesco ^a   Monaco, Cristina D I ^a   Ferri, Giovanni M ^a   Amoroso, Antonio ^a   Vaccaro, Francesco ^a   Bonomo, Lorenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; LACTOFERRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AGM 10 14; MONOCLONAL ANTIBODY AGM 2 29; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOFLUORESCENCE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 0029761765     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.263     Document Type: Article

References (22)

1. Orman JD, and Reiter B: Inhibition of bacteria by lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes. Infect Immun 1968;6:761-766.
2. Kirkpatrick CH, Green I, Rich RR, and Schade AL: Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: Relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis 1971;124:539-543.
3. Kievits F, and Kijlstra A: Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin. Immunology 1985;54:449-457.
4. Kuizenga A, van Haeringen NJ, and Kijlstra A: Inhibition of hydroxyl radical formation by human tears. Invest Ophthalmol Vis Sci 1987;28:205-213.
5. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EAM, Kleijburg-van der Keur C, and Breedveld FC: Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-1475.
6. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, and Kallemberg CGM: Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: Characterization and clinical correlations. Arthritis Rheum 1993;36:1054-1060.
7. Peen E, Almer S, Bodemar G, Rydén B-O, Sjolin C, Tejle K, and Skogh T: Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993;34:56-62.
8. Mulder AHL, Heeringa P, Brouwer E, Limburg PC, and Lallemberg CGM: Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A Fcg RII-dependent process. Clin Exp Immunol 1994;98:270-278.
9. Kearney JF, Radbruch A, Liesegang B, and Rajewsky K: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 1979;123:1548-1550.
10. Esaguy N, Aguas AP, van Embden JDA, and Silva MT: Mycobacteria and human autoimmune disease: Direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli. Infect Immun 1991;59:1117-1125.
11. Galfre G, and Milstein C: Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol 1981;73:1-46.
12. McKinney MM, and Parkinson A: A simple, non chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods 1987;96:271-278.
13. Temponi M, Kageshita T, Perosa F, Ono R, Okada H, and Ferrone S: Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: Comparison with other methods of purification. Hybridoma 1989;8:85-92.
14. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227:680-685.
15. Streicher HZ, Cuttitta F, Buckenmeyer GK, Kawamura H, Minna J, and Berzofski JA: Mapping of the idiotopes of a monoclonal anti-myoglobin antibody with syngeneic monoclonal anti-idiotypic antibodies: Detection of a common idiotope. J Immunol 1986;136:1007-1011.
16. Palma C, Serbousek D, Torosantucci A, Cassone A, and Djeu JY: Identification of a mannoprotein fraction from Candida albicans that enhances human polymorphonuclear leukocytes (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth. J Infect Dis 1992;166:1103-1112.
17. Borish L, Rosenbaum R, Albury L, and Clark S: Activation of neutrophils by recombinant interleukin 6. Cell Immunol 1989;121:280-289.
18. Jennette JC, Charles LA, and Falk RJ: Anti-neutrophil cytoplasmic antibodies: Disease association, molecular biology and pathophysiology. Int Rev Exp Pathol 1991;32:193-221.
19. Kallenberg CGM, Mulder AHL, and Cohen Tervaert JW: Anti-neutrophil cytoplasmic antibodies: A still growing class of autoanti-bodies in inflammatory disorders. Am J Med 1992;93:675-682.
20. Ludemann J, Utecht B, and Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-362.
21. Falk RJ, and Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-1657.
22. Charles LA, Falk RJ, and Jennette JC: Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol 1989;53:243-253.